Cx Device
Cervical Insufficiency / Prevention of Preterm Birth
PreclinicalActive
Key Facts
Indication
Cervical Insufficiency / Prevention of Preterm Birth
Phase
Preclinical
Status
Active
Company
About Cx Therapeutics
Cx Therapeutics is a private, preclinical biotech/medtech startup founded in 2020 and based in Cambridge, Massachusetts. The company is developing a novel medical device designed to treat cervical insufficiency, a condition leading to preterm birth, aiming to modernize the longstanding cerclage procedure. It is supported by non-dilutive grants from entities like the NIH and the Massachusetts Life Sciences Center and collaborates with academic medical centers. The company is pre-revenue and faces significant development and regulatory hurdles but targets a large, underserved global market with a high unmet need.
View full company profile